Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Wei AH, Panayiotidis P, Montesinos P, Laribi K, et al. Blood 2022;140:2754-2756.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wei AH, Panayiotidis P, Montesinos P, Laribi K, et al. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood 2022;140:2754-2756.
PMID: 36112968